@molemoon68
Active 7 months, 1 week ago
r patients with distinct chronic pain conditions.
The Work Ability in Natalizumab-Treated MS Patients (WANT) study assessed work ability, quality of life, and cognitive processing speed during natalizumab treatment.
WANT was a 1-year, prospective, multicenter observational study conducted in Italy. Inclusion criteria included […] View